Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$279,367
+$10,483 QoQ
Shares Held
1,100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#4,235
of 4,676 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Defender Capital, LLC. holds $682,345 across 2 Drug Manufacturers - General names. JNJ ranks #2 (40.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
16,735 | $402,978 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,100 | $279,367 |
All Filings in JNJ
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $279,367 | 1,100 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $268,884 | 1,100 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $261,998 | 1,266 | Shares | Sole | 2026-01-12 | |
| 2024-09-30 | $205,167 | 1,266 | Shares | Sole | 2024-10-21 | |
| 2024-03-31 | $201,059 | 1,271 | Shares | Sole | 2024-05-06 | |
| 2023-09-30 | $213,221 | 1,369 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $226,596 | 1,369 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $211,730 | 1,366 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $241,303 | 1,366 | Shares | Sole | 2023-05-16 | |
| 2022-09-30 | $223,149 | 1,366 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $242,478 | 1,366 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $242,096 | 1,366 | Shares | Sole | 2022-06-07 | |
| 2021-12-31 | $233,681 | 1,366 | Shares | Sole | 2022-02-01 | |
| No filing history on record for this holder in this stock. | ||||||